GSK3B and neurodegenerative disease: Increased GSK3β activity and concomitant disruption of transport have been reported in neurodegenerative diseases [73, 163–169] suggesting that LMTK deficiency can potentially perturb GSK3β-associated signalling cascades regulating axonal transport.